Back to Search
MICHAEL KANE, MD
MD
Medical Oncology Physician
NPI: 1487626214IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
25MA05555900(NJ)60331(CT)
Education
RUTGERS NEW JERSEY MEDICAL SCHOOL
Class of 1983
Research & Publications (20)
The utility of oral diabetes medications in type 2 diabetes of the young.
PMID 18220585·Curr Diabetes Rev·2005
6-review
Cholesterol and glycemic effects of Niaspan in patients with type 2 diabetes.
PMID 11765300·Pharmacotherapy·2001
8-other
Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays.
PMID 11071945·Nucleic Acids Res·2000
4-observational
Theory-based policy development for HIV prevention in racial/ethnic minority midlife and older women.
PMID 19199151·J Women Aging·2009
8-other
Conducting the train of thought: working memory capacity, goal neglect, and mind wandering in an executive-control task.
PMID 19210090·J Exp Psychol Learn Mem Cogn·2009
8-other
Developing a conceptual framework for an evaluation system for the NIAID HIV/AIDS clinical trials networks.
PMID 19460164·Health Res Policy Syst·2009
8-other
Development and evaluation of a PCR and mass spectroscopy (PCR-MS)-based method for quantitative, type-specific detection of human papillomavirus.
PMID 19410602·J Virol Methods·2009
4-observational
Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
PMID 19255320·J Clin Oncol·2009
3-trial
Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.
PMID 19389355·Dev Biol·2009
7-preclinical
Protocol for the assessment of potential health effects from embedded metal fragments.
PMID 19354090·Mil Med·2009
8-other
Rdh12 activity and effects on retinoid processing in the murine retina.
PMID 19506076·J Biol Chem·2009
7-preclinical
Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
PMID 19255321·J Clin Oncol·2009
3-trial
Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to therapy.
PMID 19307945·Am J Clin Oncol·2009
3-trial
Perceptions of elders' substance abuse and resilience.
PMID 19440902·Gerontol Geriatr Educ·2009
8-other
Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study.
PMID 19584772·Plast Reconstr Surg·2009
3-trial
Characterization of ontogenetic changes in gene expression in the fathead minnow (Pimephales promelas).
PMID 19391683·Environ Toxicol Chem·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 196 PARKWAY SOUTH, SUITE 303
WATERFORD, CT 06385 - Phone
- (860) 443-4455
Quick Facts
- NPI
- 1487626214
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile